Meet the team helping fight leukaemia

10 December 2018

Professor David Huang, 2018 Clunies Ross Knowledge Commercialisation Awardee, and collaborators Associate Professor Peter Czabotar and Associate Professor Guillaume Lessene talk about their role in the development of a novel, potent anti-cancer drug called venetoclax.

Read the transcript of this podcast.